• Centre’s treatment success rates exceed international average

Government of Dubai Media Office : Dubai Crown Prince and Chairman of The Executive Council HH Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum inaugurated the new building of Dubai Fertility Centre in Al Jaddaf area in Dubai.

The state-of-the-art specialised fertility treatment centre offers a comprehensive range of innovative infertility treatment solutions.

The Crown Prince was welcomed at the Centre by Director General of the Dubai Health Authority (DHA) Awad Saghir Al Ketbi, Deputy Director General of the Dubai Health Authority Dr. Alawi Alsheikh Ali and senior DHA staff.

Following the inauguration ceremony, Sheikh Hamdan toured the new facility. During his tour, the Director of Dubai Fertility Centre Hana Tahwara briefed His Highness on the new services offered by the Centre and its treatment success rates which exceed the international average.

Since its establishment in 1991, 5,099 babies have been born as a result of the treatment provided by the Centre. Between 2017 and 2020, the Centre received an average of 14,000 patients annually and provided treatment to 24,000 families.

The Director General of DHA Awad Saghir Al Ketbi said the Dubai remarkable advances made by the Authority have been made possible by the government’s steadfast support. The DHA will continue to develop its facilities and services to help realise the leadership’s vision for the sector.

Al Ketbi further said the Dubai Fertility Centre provides treatment to families both from within the UAE and outside the country. The DHA aims to develop the Centre into the best specialised fertility treatment centre in the world by providing it the latest technology and equipment and the best experts in the field. Along with other public and private healthcare facilities, the Centre will help enhance the offerings of the emirate’s medical tourism sector and attract more medical researchers and professionals to the country.

-Ends-

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.